Archives
Nintedanib in ATRX-Deficient Glioma
2026-08-29
Nintedanib (BIBF 1120) offers a practical way to test coordinated VEGFR, FGFR, and PDGFR blockade in genotype-stratified cancer models. This workflow connects ATRX status, apoptosis measurements, and temozolomide combination studies while addressing formulation, exposure, and interpretation challenges.
2% Phosphotungstic Acid for Translational Virus Imaging
2026-08-28
Conserved coronavirus glycans offer a compelling antiviral target, but translational teams need reliable structural quality control alongside functional assays. This thought-leadership article explains how Phosphotungstic Acid Negative Stain Solution (2%) can support virus imaging, particle-quality assessment, and decision-making across glycan-focused antiviral workflows—while clarifying what negative stain electron microscopy can and cannot prove.
Smoothened Signaling and Olfaction in Honeybees
2026-08-28
Guo et al. characterized Smoothened (Smo) in Apis mellifera and linked pharmacological Smo inhibition or activation with olfactory receptor expression, antennal electrophysiology, and odor-guided behavior. The study provides a multi-level framework for examining Hedgehog signaling in insect sensory biology while emphasizing that its high-dose feeding paradigm should not be directly equated with mammalian regenerative applications.
Cx43/NF-κB Signaling in AngII Macrophage Polarization
2026-08-28
The reference study identifies connexin 43 and NF-κB p65 as linked regulators of angiotensin II–induced M1-like polarization in RAW264.7 macrophages. Its combined inhibitor, protein, transcript, cytokine, and phenotyping strategy provides a useful framework for testing how connexin signaling contributes to vascular inflammation while highlighting the need to distinguish hemichannel effects from broader Cx43 activity.
Measuring Anticancer Drug Response In Vitro
2026-08-27
Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but not interchangeable outcomes. The framework encourages time-aware, mechanism-sensitive interpretation of anticancer assays, including studies of targeted cell-cycle drugs.
DiscoveryProbe Protease Inhibitor Library Strategy
2026-08-26
The DiscoveryProbe Protease Inhibitor Library supports a layered strategy for protease inhibition, from biochemical screening to cellular mechanism. This article explains how to interpret library diversity, control assay artifacts, and connect HTS results with defensible biological conclusions.
MK-1775: From Checkpoint Biology to Translation
2026-08-26
MK-1775 is a selective Wee1 kinase inhibitor for dissecting G2 checkpoint control, DNA damage response inhibition, and chemotherapy sensitization. This thought-leadership guide connects mechanism with rigorous in vitro response measurement and translational study design.
Rifampin Workflows for Bacterial Transcription
2026-08-26
Rifampin provides a practical, target-focused way to interrupt bacterial transcription and connect early RNA effects with downstream loss of viability. This workflow guide covers stock preparation, time-course design, resistance studies, synthetic circuits, and troubleshooting for reproducible antibiotic drug research.
JXY Reprograms Macrophages in Colitis-Associated CRC
2026-08-25
Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. The study combines orthotopic disease modeling, tissue pathology, macrophage phenotyping, functional assays, and pharmacological pathway interrogation to connect immune reprogramming with reduced tumor burden.
Ang II–HIF-1α-HILPDA Axis in NPC Radioresistance
2026-08-24
This study identifies a local angiotensin II–AGT–HIF-1α–HILPDA circuit that suppresses ferroptosis and promotes radiotherapy resistance in nasopharyngeal carcinoma. Its experimental framework supports combined angiotensin receptor blockade and ferroptosis induction as a preclinical radiosensitization strategy, while also defining candidate biomarkers for further validation.
Dovitinib Workflow for RTK Cancer Assays
2026-08-24
Build reproducible RTK, signaling, and apoptosis assays with Dovitinib while separating pathway potency from phenotypic response. A radiopathomics-inspired strategy adds orthogonal imaging, molecular, and viability readouts to make translational conclusions more robust.
PD0325901 MEK Inhibitor Workflow Guide
2026-08-23
PD0325901 provides a practical way to connect MEK activity with P-ERK signaling, cell-cycle behavior, apoptosis, and tumor phenotypes. This guide combines oncology workflows with a carefully bounded extension into blastoid and metabolic assays inspired by recent WDR36 research.
SCH772984: ERK1/2 Inhibitor Workflow
2026-08-22
SCH772984 enables selective, nanomolar interrogation of ERK1/2 signaling in BRAF-, NRAS-, and KRAS-driven cancer models. This workflow extends that established pharmacology into radiation, ferroptosis, and nasopharyngeal carcinoma assays while clearly separating validated product evidence from hypothesis-generating applications.
AZD3463: ALK/IGF1R Inhibitor Workflow
2026-08-21
AZD3463 gives researchers a dual-pathway approach to interrogate ALK- and IGF1R-dependent signaling in neuroblastoma models, including activating ALK variants and chemotherapy combinations. This workflow connects target engagement, PI3K/AKT/mTOR pathway readouts, apoptosis, autophagy, and translational assay design while clearly separating established findings from practical recommendations.
U0126: From MEK Biology to Translational Strategy
2026-08-20
U0126 is more than a pathway inhibitor: it is a mechanistic probe for separating MEK/ERK signaling from ROS–p38 biology, stress adaptation, and degradative pathways. This thought-leadership guide translates evidence from orofacial neuropathic pain research into rigorous experimental strategies for neurobiology, cancer biology research, and broader translational studies.
607 records 10/41 page Previous Next First page 上5页 678910 下5页 Last page